INFUSYSTEM HOLDINGS INC (INFU)
US45685K1025 - Common Stock
Overall INFU gets a fundamental rating of 4 out of 10. We evaluated INFU against 118 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of INFU get a neutral evaluation. Nothing too spectacular is happening here. INFU is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year INFU has reported negative net income.
INFU had a positive operating cash flow in the past year.
In the past 5 years INFU has always been profitable.
Each year in the past 5 years INFU had a positive operating cash flow.
1.2 Ratios
INFU has a Return On Assets (0.08%) which is in line with its industry peers.
INFU's Return On Equity of 0.16% is fine compared to the rest of the industry. INFU outperforms 61.54% of its industry peers.
With a Return On Invested Capital value of 3.02%, INFU perfoms like the industry average, outperforming 54.70% of the companies in the same industry.
INFU had an Average Return On Invested Capital over the past 3 years of 2.62%. This is significantly below the industry average of 8.65%.
The 3 year average ROIC (2.62%) for INFU is below the current ROIC(3.02%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.08% | ||
| ROE | 0.16% | ||
| ROIC | 3.02% |
ROA(3y)0.77%
ROA(5y)4.38%
ROE(3y)1.55%
ROE(5y)10.65%
ROIC(3y)2.62%
ROIC(5y)4.43%
1.3 Margins
INFU has a Profit Margin (0.07%) which is in line with its industry peers.
INFU's Profit Margin has declined in the last couple of years.
INFU has a Operating Margin (2.63%) which is in line with its industry peers.
INFU's Operating Margin has improved in the last couple of years.
INFU's Gross Margin of 50.27% is amongst the best of the industry. INFU outperforms 80.34% of its industry peers.
In the last couple of years the Gross Margin of INFU has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.63% | ||
| PM (TTM) | 0.07% | ||
| GM | 50.27% |
OM growth 3Y-28.96%
OM growth 5Y39.37%
PM growth 3Y-66.1%
PM growth 5YN/A
GM growth 3Y-5.96%
GM growth 5Y-3.17%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INFU is destroying value.
Compared to 1 year ago, INFU has more shares outstanding
Compared to 5 years ago, INFU has more shares outstanding
The debt/assets ratio for INFU has been reduced compared to a year ago.
2.2 Solvency
INFU has an Altman-Z score of 2.23. This is not the best score and indicates that INFU is in the grey zone with still only limited risk for bankruptcy at the moment.
INFU has a Altman-Z score of 2.23. This is comparable to the rest of the industry: INFU outperforms 59.83% of its industry peers.
INFU has a debt to FCF ratio of 9.23. This is a negative value and a sign of low solvency as INFU would need 9.23 years to pay back of all of its debts.
INFU's Debt to FCF ratio of 9.23 is fine compared to the rest of the industry. INFU outperforms 62.39% of its industry peers.
INFU has a Debt/Equity ratio of 0.57. This is a neutral value indicating INFU is somewhat dependend on debt financing.
The Debt to Equity ratio of INFU (0.57) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 9.23 | ||
| Altman-Z | 2.23 |
ROIC/WACC0.36
WACC8.31%
2.3 Liquidity
INFU has a Current Ratio of 1.87. This is a normal value and indicates that INFU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.87, INFU is in the better half of the industry, outperforming 71.79% of the companies in the same industry.
INFU has a Quick Ratio of 1.51. This is a normal value and indicates that INFU is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of INFU (1.51) is better than 63.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.87 | ||
| Quick Ratio | 1.51 |
3. Growth
3.1 Past
INFU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 922337203685477632.00%, which is quite impressive.
Measured over the past years, INFU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -63.04% on average per year.
INFU shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.23%.
INFU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.38% yearly.
EPS 1Y (TTM)922337203685477600%
EPS 3Y-63.04%
EPS 5YN/A
EPS growth Q2Q-150%
Revenue 1Y (TTM)12.23%
Revenue growth 3Y8.9%
Revenue growth 5Y13.38%
Revenue growth Q2Q5.35%
3.2 Future
The Earnings Per Share is expected to grow by 149.97% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 8.34% on average over the next years. This is quite good.
EPS Next Y441.88%
EPS Next 2Y259.3%
EPS Next 3Y149.97%
EPS Next 5YN/A
Revenue Next Year9.03%
Revenue Next 2Y9.29%
Revenue Next 3Y8.34%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Forward Earnings ratio is 15.59, which indicates a correct valuation of INFU.
Based on the Price/Forward Earnings ratio, INFU is valued a bit cheaper than 74.36% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.20. INFU is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 15.59 |
4.2 Price Multiples
76.07% of the companies in the same industry are more expensive than INFU, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INFU is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.21 | ||
| EV/EBITDA | 10.54 |
4.3 Compensation for Growth
INFU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as INFU's earnings are expected to grow with 149.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y259.3%
EPS Next 3Y149.97%
5. Dividend
5.1 Amount
INFU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INFUSYSTEM HOLDINGS INC
NYSEARCA:INFU (5/17/2024, 7:06:12 PM)
After market: 6.44 0 (0%)6.44
+0.1 (+1.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap136.91M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 15.59 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.08% | ||
| ROE | 0.16% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 2.63% | ||
| PM (TTM) | 0.07% | ||
| GM | 50.27% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.87 | ||
| Quick Ratio | 1.51 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)922337203685477600%
EPS 3Y-63.04%
EPS 5Y
EPS growth Q2Q
EPS Next Y441.88%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.23%
Revenue growth 3Y8.9%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y